Gilead Sciences
GILD
#129
Rank
โ‚น13.549 T
Marketcap
โ‚น10,920
Share price
0.36%
Change (1 day)
42.96%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): โ‚น858.50 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are โ‚น29.08 Billion. In 2024 the company made an earning of โ‚น62.21 Billion a decrease over its 2023 earnings that were of โ‚น618.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น858.50 B1279.85%
2024 โ‚น62.21 B-89.94%
2023 โ‚น618.47 B17.97%
2022 โ‚น524.24 B-29.77%
2021 โ‚น746.42 B395.99%
2020 โ‚น150.49 B-67.66%
2019 โ‚น465.27 B-33.84%
2018 โ‚น703.23 B-42.35%
2017 โ‚น1.219 T-20.87%
2016 โ‚น1.541 T-21.06%
2015 โ‚น1.952 T45.8%
2014 โ‚น1.339 T253.01%
2013 โ‚น379.45 B16.51%
2012 โ‚น325.69 B-1.07%
2011 โ‚น329.21 B-6.71%
2010 โ‚น352.88 B11.75%
2009 โ‚น315.77 B29.5%
2008 โ‚น243.83 B19.11%
2007 โ‚น204.71 B-455.74%
2006 -โ‚น57.55 Billion-154.93%
2005 โ‚น104.75 B76.99%
2004 โ‚น59.18 B-266.16%
2003 -โ‚น35.63 Billion-638.24%
2002 โ‚น6.61 B31.5%
2001 โ‚น5.03 B-242.15%
2000 -โ‚น3.55 Billion-40.2%
1999 -โ‚น5.93 Billion31.85%
1998 -โ‚น4.5 Billion8.73%
1997 -โ‚น4.13 Billion27.22%
1996 -โ‚น3.25 Billion
1994 -โ‚น3.1 Billion26.57%
1993 -โ‚น2.45 Billion46.49%
1992 -โ‚น1.67 Billion362.5%
1991 -โ‚น0.37 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น743.36 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น402.29 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น149.68 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น89.71 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.68 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.068 T 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.921 T 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.029 T 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.082 T 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA